Antibe Therapeutics, Inc.Antibe Therapeutics, Inc.Antibe Therapeutics, Inc.

Antibe Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate

About Antibe Therapeutics, Inc.


Headquarters
Toronto
Founded
2009
FIGI
BBG006YTKW75
Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the Antibe Therapeutics and Citagenix segments. The Antibe Therapeutics segment focuses on the development of pharmaceutical products. The Citagenix segment is involved in the development and sale of regenerative medicines serving the dental and orthopedic marketplaces. The company was founded by Andre Buret, John Wallace, and Giuseppe Cirino on May 5, 2009 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ATBPF is 0.2156 USD — it has increased by 13.47% in the past 24 hours. Watch Antibe Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Antibe Therapeutics, Inc. stocks are traded under the ticker ATBPF.
ATBPF reached its all-time high on Jun 1, 2020 with the price of 64.0400 USD, and its all-time low was 0.1113 USD and was reached on Apr 1, 2024. View more price dynamics on ATBPF chart.
See other stocks reaching their highest and lowest prices.
ATBPF stock is 29.80% volatile and has beta coefficient of −2.44. Track Antibe Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Antibe Therapeutics, Inc. there?
Yes, you can track Antibe Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Antibe Therapeutics, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
No, ATBPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATBPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Antibe Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Antibe Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Antibe Therapeutics, Inc. stock shows the strong sell signal. See more of Antibe Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.